By Justin Leader
With the enhanced ACA subsidies set to expire and insurers filing for 15–20%+ premium increases in 2026, many are bracing for what could be a massive affordability shock for middle-class families, especially those who have relied on expanded subsidies since 2021.
Continue reading ACA Premium Hikes, Expiring Subsidies, and the ICHRA Ripple Effect: What to Watch in 2026
“Cost of Obamacare is expected to soar” headlines the reporter. Not true. Other than the usual annual rate increases we’ve experienced every year for the past 40, the cost hasn’t increased at all. In fact the opposite is true…………for the first time in living memory the cost has decreased.
Continue reading Cost of Obamacare Goes Down Despite Fake News Report
“Monte’s Ancestor? The ability to predict future trends before others do is a common trait of futurists. Monte Jennings insists the future is now and he’s here to lead it” – Molly Mulebriar
Continue reading Monte “Nostradamus” Jennings Declares The Future is Now
We are beginning to see pharmaceutical manufacturers breaking away from supply chain middlemen (PBMs) saving consumers imbedded commissions (rebates) for savings of 40% and more. For example Novo Nordisk Direct and Lilly Direct offer certain GLP-1 drugs for $500 or less, a more than 50% price drop.
Continue reading Another Pharma Mfg. Bypasses Middlemen – Costs Drop More Than 40%